Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HERBALIFE LTD. Director's Dealing 2022

Aug 2, 2022

32337_dirs_2022-08-02_1f455647-ad66-430b-b59b-c20b9f6123b8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: HERBALIFE NUTRITION LTD. (HLF)
CIK: 0001180262
Period of Report: 2022-07-29

Reporting Person: Lamberti Frank (Regional Pres. Americas)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 106362 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Appreciation Rights $39.79 2023-12-19 Common Stock (5675) Direct
Stock Appreciation Rights $29.99 2024-04-30 Common Stock (7217) Direct
Stock Appreciation Rights $15.22 2025-03-02 Common Stock (14070) Direct
Stock Appreciation Rights $27.375 2026-02-28 Common Stock (12540) Direct
Stock Appreciation Rights $31.255 2026-05-09 Common Stock (30231) Direct
Stock Appreciation Rights $28.595 2027-02-27 Common Stock (31779) Direct

Footnotes

F1: Balance includes 59,986 unvested restricted stock units ("RSUs") previously granted to the Reporting Person, of which: 2,576 RSUs will vest on February 20, 2023; 672 will vest on February 19, 2023 and 2,018 will vest on February 19, 2024; and 887 will vest on February 25, 2023, 887 will vest on February 25, 2024 and 2,662 will vest on February 25, 2025. Each of the aforementioned grants are are subject to the following vesting schedule: 20% on the first and second anniversaries of the grant date and 60% on the third anniversary of the grant date. Additionally, 50,284 RSUs, which were granted on April 7, 2020, will vest 100% on April 7, 2023. All RSU vestings are subject to continued service through each applicable date. Also consists of 21,086 shares of the Issuer's common stock to which the Reporting Person became entitled upon vesting of RSUs, receipt of which the Reporting Person has elected to defer.

F2: These stock appreciation rights were fully vested as of June 21, 2016.

F3: These stock appreciation rights were fully vested as of April 30, 2017.

F4: These stock appreciation rights were fully vested as of March 2, 2018.

F5: These stock appreciation rights were fully vested as of February 28, 2019.

F6: These stock appreciation rights were fully vested as of May 9, 2019.

F7: These stock appreciation rights were fully vested as of February 27, 2020.